Free FAAID Practice Questions

Question 1

A maxillary central incisor with a chronic apical lesion is removed. There is no sinus tract or acute infection, debridement is complete, and the facial wall remains intact. An implant achieves primary stability in the planned restorative position, with a provisional that can be kept out of occlusion. How should the pre-extraction lesion affect the provisionalization decision?

Accepted Answer

The debrided chronic lesion does not by itself rule out immediate restoration.

Answer

Provisionalization should await radiographic disappearance of the apical lesion.

Answer

Connection of a provisional should follow a completed course of systemic antibiotics.

Answer

The original radiolucency should be treated as residual infection preventing provisionalization.

Question 2

A rigid verification index seats without strain over a patient’s implants but will not fully seat over the left posterior analog on the master cast. The definitive fixed prosthesis fits that cast, yet lifts at the opposite end during a one-screw intraoral test. Where should correction begin?

Accepted Answer

Correct the transferred implant positions and remake the affected master cast.

Answer

Relieve the prosthesis tissue surface and reassess seating.

Answer

Adjust the opposing occlusal contacts before repeating the prosthesis fit assessment.

Answer

Increase screw torque sequentially until all of the lifted interfaces are closed.

Question 3

A 50-year-old patient seeking implant treatment has generalized interdental CAL reaching 6 mm, probing depths reaching 7 mm, and radiographic bone loss of 40% at the most affected tooth. Three teeth were lost to periodontitis; 24 remain. Chewing and occlusion are stable, with no secondary occlusal trauma or severe ridge defects. Previous periodontal records are unavailable. The patient smokes 12 cigarettes daily and does not have diabetes. Which stage and grade best describe the periodontitis?

Accepted Answer

Stage III, Grade C

Answer

Stage IV, Grade B

Answer

Stage III, Grade B

Answer

Stage IV, Grade C

Question 4

A 76-year-old taking warfarin has localized oral candidiasis beneath a maxillary implant overdenture. Anticoagulation has been stable, with a recent INR of 2.6. There is no dysphagia or fever. Which prescription treats the candidiasis with the least avoidable disruption to anticoagulation?

Accepted Answer

Nystatin suspension while maintaining the established warfarin regimen.

Answer

Miconazole oral gel, with no anticoagulation review because its application is topical.

Answer

Delay antifungal treatment until warfarin can be withheld and the INR normalizes.

Answer

Fluconazole tablets without additional anticoagulation monitoring.

Question 5

An 81-year-old with an edentulous maxilla has poor retention despite a well-extended conventional denture. A diagnostic setup confirms that a facial flange is needed for lip support. Arthritis limits cleaning beneath a fixed bridge, but an adapted grip lets the patient remove and clean a denture. Bone permits four appropriately distributed implants. Which design best meets these functional constraints?

Accepted Answer

A removable implant overdenture with a facial flange and accessible attachments

Answer

A conventional complete denture with increased border extension for added retention

Answer

A fixed complete prosthesis with elongated crowns to restore the facial contour

Answer

A fixed complete prosthesis with a facial flange extending close to the mucosa

Question 6

A 60-kg patient with stable coronary disease needs additional local anesthesia during implant surgery. One 1.7-mL cartridge of 2% lidocaine with epinephrine 1:100,000 has been given. The agreed plan limits total epinephrine to 0.04 mg, and no other local anesthetic has been used. Which assessment correctly identifies the remaining dosing margin?

Accepted Answer

One more cartridge fits both limits; epinephrine is the tighter constraint.

Answer

Two more cartridges are acceptable because the lidocaine dose remains below 7 mg/kg.

Answer

Further supplementation must be epinephrine-free to remain within the agreed cardiac limit.

Answer

Three more cartridges are acceptable because each contains 0.01 mg of epinephrine.

Question 7

Ten weeks after nonsurgical treatment for peri-implant mucositis, an implant still bleeds at three probing sites. Probing depths are 4 mm, there is no suppuration, and radiographs show no additional bone loss. Plaque remains beneath a bulky distal crown contour that the patient cannot reach with an interdental aid. What should be changed in the treatment approach?

Accepted Answer

Repeat mechanical plaque removal and modify the crown to permit effective cleaning.

Answer

Proceed to surgical implant decontamination because bleeding persisted after a course of nonsurgical care.

Answer

Resume annual surveillance because stable radiographic bone levels establish a satisfactory treatment endpoint.

Answer

Add systemic antibiotics to suppress the residual inflammation before reassessing the crown contour.

Question 8

During lateral-window sinus augmentation for two posterior maxillary implants, the membrane remains intact, but the residual ridge cannot provide reliable primary fixation. Implant positions and dimensions cannot be changed safely. The patient had expected both grafting and implant placement at this visit. The surgeon should:

Accepted Answer

Complete augmentation and stage implant placement after graft healing

Answer

Place both implants now and splint them with a nonoccluding provisional

Answer

Place both implants now and use a longer unloaded healing interval

Answer

Place both implants now and obtain their support from the packed graft

Question 9

A 71-year-old woman receiving denosumab for osteoporosis requests replacement of a missing premolar. Periodontal inflammation is controlled, and she has no exposed bone, fistula or unexplained jaw symptoms. A serum CTX result obtained elsewhere is below the laboratory reference interval. She asks whether that result means an implant is unsafe. Which response best supports the treatment decision?

Accepted Answer

Assess clinical risk and obtain informed consent; CTX cannot establish surgical safety.

Answer

Suspend planning until CTX normalizes after a prescriber-supervised interruption of denosumab.

Answer

Recommend a conventional bridge because antiresorptive treatment excludes implant placement.

Answer

Proceed without specific MRONJ counseling because the denosumab indication is osteoporosis.

Question 10

A fixed complete implant prosthesis has recurrent loosening at its distal connection. Passive fit and component compatibility are satisfactory. The distal cantilever carries a heavy contact, and a replacement design can shorten it without compromising the tooth arrangement. For the same applied force, shortening the extension primarily reduces:

Accepted Answer

Bending moment at the supporting connection

Answer

Manufacturer-specified screw-tightening torque

Answer

Coefficient of friction within the screw joint

Answer

Elastic modulus of the restorative framework

Free FAAID Practice Questions

Domain 1: Patient Examination

Question 1

Question 2

Question 3

Domain 2: Development of the Treatment Plan

Question 4

Question 5

Question 6

Domain 3: Surgical and Prosthetic Report

Question 7

Question 8

Question 9

Domain 4: Clinical Résumé

Question 10

That's 10 of 1,030